MindMaze Therapeutics Holding SA
MMTZF · OTCMCIK 1854078fmd_0Q3CJSWJ4BMMK9WKH213FGP4E6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Dec 31, 2023, 4 periods
| Line item | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Total revenues | 4 | 7 | 6 |
| Research and development | 19 | 12 | 1 |
| Operating income | (34) | (52) | (111) |
| Interest expense | 1 | 2 | 1 |
| Income before taxes | (36) | (54) | (112) |
| Income tax expense | (1) | (4) | (14) |
| Net income from continuing operations | (35) | (51) | (98) |
| Net income | (35) | (51) | (98) |